Aveanna Healthcare Holdings, Inc.
AVAH NasdaqΒ· Services-Home Health Care Services
Last close Β· Oct 23, 2026
$13.38
KIRA Β· Stoqlyβs AI analyst, in plain words
- Aveanna Healthcare Holdings, Inc. had $2.4B of revenue in fiscal 2026, up 20.2% on the year before. Over five years, revenue changed +10.2% a year on average.
- Its operating margin was 10.5%, up 3.6Β pts: of every 100 in sales, about 11 is left after running the business.
- Aveanna Healthcare Holdings, Inc. made $225M of net profit in fiscal 2026.
- Aveanna Healthcare Holdings, Inc. owes $1.1B more than it holds in cash, about 4.1 years of operating profit.
Market cap
$3.0B
P/E
10.6x
Revenue
$2.4B
Net income
$225M
Free cash flow
β
Operating margin
10.5%
Aveanna Healthcare Holdings, Inc. in 30 seconds Β· fiscal 2026
Are sales growing?
+20.2%
Yes. Sales grew 20.2% last year.
Does it make a profit?
9.2%
A little. It keeps 9.2% of every sale as profit.
Is debt under control?
4.1x
Heavy. Repaying its debt would take 4.1 years of operating profit.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
10.6x
One share costs 10.6 times its yearly profit per share.
What Aveanna Healthcare Holdings, Inc. does
No business description yet.
- Fiscal year ends
- January 3, 2026
- Latest annual report
- 10-K Β· Mar 19, 2026
- Legal name
- Aveanna Healthcare Holdings, Inc.
- CIK
- 0001832332
Aveanna Healthcare Holdings, Inc. Β· AVAH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.7B | $1.8B | $1.9B | $2.0B | $2.4B |
| Revenue growth | 12.3% | 6.5% | 6.0% | 6.8% | 20.2% |
| Gross margin | 32.3% | 30.9% | 31.4% | 31.4% | 33.3% |
| Operating margin | β2.2% | β35.9% | 0.4% | 6.9% | 10.5% |
| Net income | β$117M | β$662M | β$135M | β$10.9M | $225M |
| Net margin | β7.0% | β37.0% | β7.1% | β0.5% | 9.2% |
| Diluted EPS | β$0.69 | β$3.57 | β$0.71 | β$0.06 | $1.05 |
| Cash | |||||
| Cash from operations | β$11.4M | β$48.4M | $22.7M | $32.6M | $126M |
| Capital expenditure | $16.0M | β | β | β | β |
| Free cash flow | β$27.3M | β | β | β | β |
| FCF margin | β1.6% | β | β | β | β |
| Share count change | β99.9% | 108,664.9% | 2.4% | 1.5% | 11.4% |
| Debt and strength | |||||
| Cash and short-term investments | $30.5M | $19.2M | $43.9M | $84.3M | $193M |
| Debt incl. finance leases | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B |
| Shareholders' equity | $636M | β$6.3M | β$130M | β$124M | $194M |
| Net debt / EBITDA | β | β | 56.8x | 7.9x | 4.1x |
| Current ratio | 0.8x | 0.8x | 0.9x | 1.0x | 1.3x |
| Interest coverage | β0.5x | β6.0x | 0.1x | 0.9x | 1.8x |
| Returns and quality | |||||
| Return on capital | β1.6% | β40.1% | 0.6% | 8.5% | 19.7% |
| Return on equity | β26.0% | β210.3% | β | β | 634.7% |
| Piotroski F-score | 4 | 3 | 6 | 6 | 6 |
| Altman Z'' | β0.7 | β5.1 | β3.0 | β2.3 | β0.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$487M
9 insiders
Of sales under plans
2%
$7.6M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Aveanna Healthcare Holdings, Inc. Β· AVAH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $13.38 a share, the company is worth $3.0B: 10.6 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001832332). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
